Publication dates

Cancer Vaccine Industry, March 2015 Market Reports from Top Publishers

You might be interested in: cancer, therapeutics, drug, medical equipment, cancer drug, vaccine, cancer immunotherapy, cervical cancer, immunotherapy, biomedical, biotherapeutics, colorectal cancer, drug delivery, hormone, hospital.


 
1-10 of about 100 reports for Cancer Vaccine

Vaccine Market by Technology, Type, End User, Disease Indication - Forecasts to 2019

Vaccine Market by Technology, Type, End User, Disease Indication - Forecasts to 2019

  • $ 4 650
  • Industry report
  • January 2015
  • by MarketsandMarkets

The vaccines market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%. The global vaccines market is categorized on the basis of type, technology, disease ...

Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

ImmunoVaccine Technologies Inc. (Symbol:IMV) SWOT Analysis, Strategy, Revenues and Profits

ImmunoVaccine Technologies Inc. (Symbol:IMV) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Cancer Vaccines Drug Pipeline Update 2015

Cancer Vaccines Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite years of R&D, a reproducible survival benefit has ...

Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach $4.3 billion in 2019, registering a compound ...

Cancer Vaccine Partnering Terms and Agreements

Cancer Vaccine Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • December 2014
  • by Currentpartnering

The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. Trends ...

Omnimmune Holdings, Inc. (Symbol:OMMH) SWOT Analysis, Strategy, Revenues and Profits

Omnimmune Holdings, Inc. (Symbol:OMMH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

KAEL-GemVax Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

KAEL-GemVax Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary KAEL-GemVax Co.,Ltd. (KAEL-GemVax) is a manufacturer of pharmaceutical products. The company develops and commercializes vaccines for the treatment of cancer using its technology. Its pipeline ...

Affitech AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Affitech AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Affitech A/S (Affitech) is a biopharmaceutical company. The company discovers and develops human antibody therapeutics for various diseases. Affitech offers products such as AT001, AT004, AT005, ...

Altor BioScience Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Altor BioScience Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Altor BioScience Corporation (Altor) is a biopharmaceutical company. The company discovers, develops and commercializes targeted immunotherapeutic agents for the treatment of cancer, viral infections, ...

About 600 reports for Cancer Vaccine

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Europe

  • April 2013
    62 pages
  • Cancer  

  • Europe  

    World  

    United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.